Will buy back though.
Watch as it runs up and a gap up tomorrow on news on presentation. This was a planned event by market makers and shorts to naked short this stock. Start buying back in or mis sthis run up.
No bad news, just a bear raid so these skums shorts can eat this week. Next week will be no eating for these basturds. It is all a scam to take your shares. Taking out all stops and will rise on a huge volume todat at the close. Insiders are still buying here.
Oncodoc, I chatted with the patient and it was explained as Cabo, I am not sure if there is another treatment named Carbo. I really just heard the words Cabo aS how it was explained to me. Also I remembered that Cabo was in combo treatment so I didn't question the Patient's ability on their spelling. Maybe you might have a much better Idea than I do or the patient. Sometime people get mixed up on names and spelling. I just reported what I heard. Thanks, hope to hear more from you if you found out anything else. Thanks again.
Just happened to run across a patient who is using Cabo in combo with Abraxane, treatment for 6 weeks using Abraxane and 2 weeks with Cabo showed no tumors in scans. No evolving pulmonary nodules or masses were seen, no plural effusion was observed either. For a treatment in Non-small lung cancer, this treatment have shown unbelievably progress with a patient with stage IV lung Cancer. The treating Oncologist was pleased with treatment.
At what price? With so many pots on their fires that exel's currently have, it may be prudent for Roche to take an overall look at exel's progress towards bringing Cometric,I and II , along with the many other Cancer trials that exel currently has. I believe with a conservative offer of $25.00 a share, it may be a reason for Exel to consider selling as a package.
Cheap shares before results in Dec 2013 and may also get a Partner to send 2 other Compounds to trials. A good time to own this.
According to the CDC article, they are no explanation for the increase in thyroid Cancers.